findmyKOL
Clinical trialNCT03285295CompletedInterventional

Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

SponsorAbbott Diagnostics DivisionEnrollment106,881Healthy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Biotest Pharmaceuticals Corporation

    Boca Raton, Florida, United States

  • American Red Cross National Testing Laboratory

    St Louis, Missouri, United States

  • Csl Plasma Inc.

    Knoxville, Tennessee, United States

  • Qualtex Laboratories

    San Antonio, Texas, United States

  • Bloodworks Northwest

    Renton, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Sept 2017
Primary completion
23 May 2018
Completion
21 Jun 2018
Last update posted
9 Oct 2019
Registered enrollment
106,881
Registry id
NCT03285295

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.